Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Sleeping Cancer Cells can ‘Wake Up’ after Decades

publication date: Jun 18, 2015
 | 
author/source: The Institute of Cancer Research

Scientists believe they have explained why some cancers that appear to have been cured can recur many years or even decades later.

ICRIt is well known that in rare cases, cancers can come back even when patients have been free of disease for so long that doctors regard them as cured.

Now researchers at The Institute of Cancer Research, London, have found genetic evidence that cancer cells can go to sleep – avoiding the effects of treatment – only to ‘wake up’ many years later.

Their study could suggest ways of rooting out dormant cancer cells – eradicating the small risk that cancer could return after appearing to be cured.

The research, published in the journal Leukemia today (Thursday), is unique because researchers had access to blood and bone marrow samples over a 20-year period from a patient with a rare form of leukaemia.

The research was funded by Leukaemia & Lymphoma Research, with additional support from the European Hematology Association, The Kay Kendall Leukaemia Fund and The Wellcome Trust.

Researchers analysed samples taken when the patient was diagnosed at four years’ old alongside samples taken when he [check] relapsed as a 25-year-old, after 22 years in remission.

They identified a specific DNA mutation, in which two genes called BCR and ABL1 fuse together, in cancer cells from both blood samples, taken 22 years apart. This shows a common lineage between the original and relapsing leukaemia – implying that cancer cells had resisted chemotherapy by becoming dormant, and  then ‘woken up’ after decades of slumber.

Researchers have suspected dormant cells from the original cancer were responsible for delayed relapse, but evidence has been very limited.

The cells responsible for the relapse are thought to have survived because they were growing much more slowly than other cancer cells – resisting traditional chemotherapy which attacks rapidly dividing cells.

The study gives researchers important insights that might help them root out these cells, for example by ‘waking them up’ so chemotherapy will kill them.

In their study, the reawakening cancer cells had some similarities to a group of cancer pre-cursor cells that predated even the original bout of the disease.

Researchers also found many new genetic changes had occurred in the cancer cells when the patient relapsed.

Study leader Professor Mel Greaves, Director of the Centre for Evolution and Cancer at The Institute of Cancer Research, London, said: “We have always known that in rare cases leukaemia can relapse when it appears to be cured, but what we’ve lacked is firm evidence that cancer cells can lie dormant for long periods of time.

“Our study shows a common genetic lineage linking the original leukaemia and relapsing disease decades later. It provides striking evidence of cancer evolution in action, with cancer cells able to lie dormant to avoid treatment, and then to accumulate new mutations capable of driving a new bout of disease.”

“Blood stem cells regularly fluctuate between being dormant or ‘asleep’ and dividing very quickly, so it seems cancer cells are just borrowing this trick to avoid being killed by chemotherapy. In future it might be possible to speed up the growth of these precancerous dormant cells so that they can be targeted and killed using chemotherapy, to reduce the risk of relapse even further.”

Dr Matt Kaiser, Head of Research at Leukaemia & Lymphoma Research, said: “Despite impressive cure rates for the most common form of childhood leukaemia, there are still too many children whose cancer ends up coming back. If we can build up a picture of what causes rare cases of late relapse and how we can detect and prevent it, we may be able to deliver more true cures for this terrible disease.”


more about the institute of cancer research


 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners